期刊文献+

维生素K1磷脂/胆盐混合胶束的制备及体外评价

Preparation and Characterization of Vitamin K Sodium Deoxycholate /Phospholipids-mixed Micelles
下载PDF
导出
摘要 制备维生素K1磷脂/胆盐混合胶束(VK1 MMS),并进行体外评价。用薄膜分散-超声法制备维生素K1磷脂/胆盐混合胶束。通过单因素考察,对蛋黄卵磷脂(EPC)/甘氨胆酸钠(BS)的比例、胆盐浓度、超声时间进行筛选优化,测定维生素K1磷脂/胆盐混合胶束的粒径、形态;并分别考察混合胶束考察与0.9%氯化钠注射液或5%葡萄糖注射液的稀释稳定性。当胆盐浓度为55 mg/m L,磷脂/胆盐质量比为1,超声温度为40℃时,维生素K1磷脂/胆盐混合胶束的载药量达到5 mg/m L;混合胶束平均粒径为20.9 nm,形态为类球体,具有良好的稀释稳定性。维生素K1混合胶束的制备工艺简单方便、载药量高、粒径分布理想、稳定性好,可用于开发静脉注射制剂。 The aim of present investigation is to prepare vitamin K sodium deoxycholate /phospholipids-mixed micelles and then characterize the products by in vivo evaluation,the film dispersion-ultrasound method was used to prepare Vitamin K1 mixed micelles( Vk1 MMS).A optimized formulation was obtained by screening several factors affected on the formation of Vk1 MMS,including bile salts concentration,EPC / BS ratio,and ultrasound time.Then the obtained Vk1 MMS was characterized by investigation of particle size distribution,morphology and physically compatibility with 0.9% Na Cl or 5% glucose injections.The formulations with drug load of 5 mg / m L was prepared under such optimized conditions including EPC / BS ratio of 1,bile salts concentration of 55 mg / m L and ultrasound temperature of 40 ℃.The obtained Vk1 MMS possessed an average size of 20.9 nm and a globoid shape observed by transmission electron microscope( TEM),and was physically compatible with 0.9% Na Cl or 5% glucose injections.VK1 MMS,prepared by simple and convenient method,significantly enhanced the water solubility of VK,and had improved stability and safety,thus,could be used for intravenous injection in clinic.
出处 《科学技术与工程》 北大核心 2016年第10期98-101,共4页 Science Technology and Engineering
关键词 维生素K1 混合胶束 磷脂 胆盐 vitamin K1 mixed micelles egg yolk lecithin bile salts
  • 相关文献

参考文献2

二级参考文献35

  • 1孙建宇,赖瑛.243例维生素K_1注射液不良反应分析[J].海峡药学,2007,19(7):109-111. 被引量:7
  • 2Sallee VL, Dietschy JM. Determinants of intestinal mucosal uptake of medium-chain fatty acids and alcohols. J Lipid Res 1973; 14: 475- 84.
  • 3Westergaard H, Dietschy JM. The mechanism whereby bile acid micelles increase the rate of fatty acid and cholesterol uptake into the intestinal mucosal cell. J Clin Invest 1976; 58: 97-108.
  • 4Wilson, FA. Intestinal transport of bile acids. Am J Physiol 1981; 241: G83-G92.
  • 5O'Reilly JR, Corrigan OI, O'Driscoll CM. The effect of mixed micellar systems, bile acid/fatty acids, on the solubility and intestinal absorption of clofazimine (B663) in the anesthetized rat. Int J Pharm 1994; 109: 147-94.
  • 6Garidel P, Hildebrand A, BlumeA. Membranolytic activity of bile salts: Influence of biological membrane properties and composition. Molecules 2007; 12: 2292-326.
  • 7Dangi JS, Vyas SP, Dixit VK. Effect of various lipid-bile salt mixed micelles on transfer of amphotericin-B across the everted rat intestine. Drug Dev Ind Pharm 1995; 21: 2021-7.
  • 8Wiedmann TS, Kamel L. Examination of the solubilization of drugs by bile salt micelles. J Pharm Sci 2002; 91: 1743-64.
  • 9Wiedmann TS, Liang W, Kamel L. Solubilization of drugs by physiological mixtures of bile salts. Pharm Res 2002; 19: 1203-8.
  • 10Hammad MA, Muller BW. Increasing drug solubility by means of bile salt-phosphatidylcholine-based mixed micelles, Eur J Pharm Biopharm 1998; 46: 361-7.

共引文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部